FDA's 2025 warning letter documents the firm's distribution of compounded tirzepatide vials.
The first-party site currently presents a broad weight-management category but did not expose a public product catalog naming the drugs in the scrape.
Locations in the source record
3831 Golf Drive, Suite A, Houston, TX 77018
Services named by sources
503A patient-specific compounding
Mail-order pharmacy fulfillment
Custom formulations
Direct-to-patient delivery
Hormone, wellness, peptide, sexual-wellness, and weight-management categories
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
ReviveRX identifies itself as a licensed 503A mail-order compounding pharmacy preparing patient-specific medications.
Section 503B
Not conclusively established
No exact Revive Rx match was found in the current FDA registered-outsourcing-facility check. This is not expanded into a categorical claim about every possible affiliate.
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
FDA warning-letter, Form 483, compounding-action, current 503B-registry, and Texas license sources were checked. State-board action searches outside Texas were not exhaustively completed.
U.S. Food and Drug Administration · 2025-02-07
Form FDA 483
FDA issued inspection observations to Revive Rx LLC dba Revive Rx Pharmacy in Houston.
issued
U.S. Food and Drug Administration · 2025-09-22
Warning Letter
FDA stated that investigators observed serious deficiencies in sterile-drug production and documented distribution of tirzepatide 10 mg/mL 2 mL vials labeled as 4 mL. The warning letter also describes evaluation of corrective actions.
ReviveRX is a nationwide compounding pharmacy built for healthcare providers. We prepare commercially available and custom-compounded medications in USP-compliant clean rooms and ship directly to your patients.
ReviveRX is a licensed 503A mail-order compounding pharmacy ... Founded in 2016 with a clear vision to expand access to reliable compounded medications.
During the inspection, FDA investigators documented that your firm distributed vials of Tirzepatide, 10mg/ml, 2ml, labeled as Tirzepatide, 10mg/ml, 4ml.
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
Related evidence records
Continue with records sharing source-backed directory tags.
These links are based only on shared GLP-1 relevance or 503-pathway tags; they do not assert affiliation or a dispensing relationship.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 7 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 4 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
Know when GLP-1 prices move.
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.